CIBC Asset Management
DVAX

CIBC Asset Management’s Dynavax Technologies DVAX Stock Holding History

CIBC Asset Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,517
Closed -$162K – 1391
2025
Q4 		$162K Buy
+10,517
New +$116K ﹤0.01% 1257
2014
Q4 		– Sell
-1,010
Closed -$14K – 949
2014
Q3 		$14K Hold
1,010
– – ﹤0.01% 973
2014
Q2 		$16K Hold
1,010
– – ﹤0.01% 792
2014
Q1 		$18K Buy
+1,010
New +$18.7K ﹤0.01% 1004

Other funds holding DVAX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CIBC Asset Management's DVAX Position: Q1 2026 in Review

CIBC Asset Management sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 10,517 shares — an estimated $162K sold.

CIBC Asset Management first reported a position in DVAX in Q1 2014 and held it in 4 quarters. The position peaked at $162K in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • CIBC Asset Management reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • CIBC Asset Management sold 10,517 Dynavax Technologies shares in Q1 2026, an estimated $162K.
  • CIBC Asset Management first reported a position in Dynavax Technologies in Q1 2014 and held it in 4 quarters.
  • CIBC Asset Management's Dynavax Technologies position peaked at $162K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on CIBC Asset Management's 13F filing for Q1 2026, filed 12 May 2026.